Similar to deteriorating metabolic abnormalities in the brain, the SNCA gene-related mutations could affect peripheral tissue metabolism in PD patients, which are useful in understanding the metabolic status of the brain and providing molecular signatures. The gene discussed is SNCA; the disease is Parkinson disease.